Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00487136
Status:
COMPLETED
Last Update Posted:
2012-09-28
First Post:
2007-06-13
Brief Title:
Interaction Between ABT-335 Rosuvastatin and Warfarin
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Multiple-Dose Pharmacokinetic and Pharmacodynamic Interaction Between ABT-335 Rosuvastatin and Warfarin
Status:
COMPLETED
Status Verified Date:
2012-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multiple-dose double-blind randomized single-center parallel-group study in adult male subjects in general good health
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None